SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ta-Wei Liu, Ming-Lun Yeh, Chung-Feng Huang, I.-Ling Lin, Jee-Fu Huang, Chia-Yen Dai, Yao-Li Chen, Wan-Long Chuang, Ming-Lung Yu, Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution, The Kaohsiung Journal of Medical Sciences, 2015, 31, 1, 26

    CrossRef

  2. 2
    Ming-Lung Yu, Ming-Lun Yeh, Pei-Chien Tsai, Ching-I. Huang, Jee-Fu Huang, Chung-Feng Huang, Meng-Hsuan Hsieh, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Wen-Yi Lin, Nai-Jen Hou, Zu-Yau Lin, Shinn-Cherng Chen, Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, Huge Gap Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C, Medicine, 2015, 94, 13, e690

    CrossRef

  3. 3
    Chun-Jen Liu, Ting-Chih Chen, Pei-Jer Chen, Hurng-Yi Wang, Tai-Chung Tseng, Huei-Ru Cheng, Chen-Hua Liu, Ding-Shinn Chen, Jia-Horng Kao, Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages, Journal of Gastroenterology and Hepatology, 2015, 30, 1
  4. 4
    Vincenzo Boccaccio, Savino Bruno, Optimal management of patients with chronic hepatitis C and comorbidities, Liver International, 2015, 35,
  5. 5
    Evangelista Sagnelli, Mariantonietta Pisaturo, Salvatore Martini, Caterina Sagnelli, Pietro Filippini, Nicola Coppola, Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection, Expert Opinion on Pharmacotherapy, 2014, 15, 10, 1337

    CrossRef

  6. 6
    Chung-Feng Huang, Ming-Lun Yeh, Pei-Chien Tsai, Meng-Hsuan Hsieh, Hua-Ling Yang, Ming-Yen Hsieh, Jeng-Fu Yang, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu, Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication, Journal of Hepatology, 2014, 61, 1, 67

    CrossRef

  7. 7
    H. L. Tillmann, Hepatitis C Virus Infection: When Is a Cure Not a Cure?, Journal of Infectious Diseases, 2014, 209, 1, 6

    CrossRef

  8. 8
    Edward Hsi, Chung-Feng Huang, Chia-Yen Dai, Suh-Hang Hank Juo, Wen-Wen Chou, Jee-Fu Huang, Ming-Lun Yeh, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Wan-Long Chuang, Ming-Lung Yu, Peripheral blood mononuclear cells microRNA predicts treatment outcome of hepatitis C virus genotype 1 infection, Antiviral Research, 2014, 105, 135

    CrossRef

  9. 9
    C.-J. Liu, Y.-T. Chu, W.-Y. Shau, R. N. Kuo, P.-J. Chen, M.-S. Lai, Treatment of patients with dual hepatitis C and B by peginterferon   and ribavirin reduced risk of hepatocellular carcinoma and mortality, Gut, 2014, 63, 3, 506

    CrossRef

  10. 10
    Chun-Jen Liu, Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues, Journal of Gastroenterology and Hepatology, 2014, 29, 1